References for Unique IS-2

  1. Madempudi RS, Ahire JJ, Neelamraju J, et al. Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs placebo on the symptoms management of irritable bowel syndrome in adults. Sci Rep. 2019;9:12210. doi:10.1038/s41598-019-48554-x.
  2. Sudha MR, Jayanthi N, Aasin M, et al. Efficacy of Bacillus coagulans Unique IS2 in treatment of irritable bowel syndrome in children: a double-blind, randomized placebo-controlled study. Benef Microbes. 2018;9(4):563-572. doi:10.3920/BM2017.0129.
  3. Madempudi RS, Neelamraju J, Ahire JJ, et al. Bacillus coagulans Unique IS2 in constipation: a double-blind, placebo-controlled study. Probiotics Antimicrob Proteins. 2020;12(1):335-342. doi:10.1007/s12602-019-09542-9.
  4. AEProbio. AEProbio Clinical Guide to Probiotic Products Available in the USA. 2025. Accessed January 31, 2025.
  5. Zhang T, Zhang C, Zhang J, Sun F, Duan L. Efficacy of probiotics for irritable bowel syndrome: a systematic review and network meta-analysis. Front Cell Infect Microbiol. 2022;12:859967. doi:10.3389/fcimb.2022.859967.
  6. So D, Quigley EMM, Whelan K. Probiotics in irritable bowel syndrome and inflammatory bowel disease: review of mechanisms and effectiveness. Curr Opin Gastroenterol. 2023;39(2):103-109. doi:10.1097/MOG.0000000000000902.
  7. McFarland LV, et al. Strain-specific and outcome-specific efficacy of probiotics for the treatment of irritable bowel syndrome: a systematic review and meta-analysis. eClinicalMedicine. 2021;41:101154.
  8. Xie P, Luo M, Deng X, Fan J, Xiong L. Outcome-specific efficacy of different probiotic strains and mixtures in irritable bowel syndrome: a systematic review and network meta-analysis. Nutrients. 2023;15(17):3856. doi:10.3390/nu15173856.